Insider Transactions in Q3 2021 at Cano Health, Inc. (CANO)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2021
|
Mark Novell Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,023
+50.0%
|
-
|
|
Sep 21
2021
|
David J Armstrong |
BUY
Grant, award, or other acquisition
|
Direct |
285,333
+48.72%
|
-
|
|
Sep 21
2021
|
Richard Aguilar Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
285,333
+41.01%
|
-
|
|
Sep 21
2021
|
Brian D Koppy Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
190,000
+50.0%
|
-
|
|
Sep 21
2021
|
Marlow Hernandez |
BUY
Grant, award, or other acquisition
|
Direct |
1,339,500
+31.92%
|
-
|
|
Aug 31
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Indirect |
2,500
+3.57%
|
$27,500
$11.99 P/Share
|
|
Aug 31
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
5,833
+0.38%
|
$64,163
$11.99 P/Share
|
|
Aug 30
2021
|
Richard Aguilar Chief Clinical Officer |
BUY
Open market or private purchase
|
Direct |
1,749
+1.38%
|
$19,239
$11.93 P/Share
|
|
Aug 30
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
1,179,109
+22.7%
|
$12,970,199
$11.31 P/Share
|
|
Aug 30
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Indirect |
2,500
+3.7%
|
$27,500
$11.92 P/Share
|
|
Aug 27
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Indirect |
2,500
+3.84%
|
$27,500
$11.77 P/Share
|
|
Aug 27
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
5,833
+1.73%
|
$64,163
$11.84 P/Share
|
|
Aug 26
2021
|
Richard Aguilar Chief Clinical Officer |
BUY
Open market or private purchase
|
Direct |
72,013
+36.85%
|
$792,143
$11.99 P/Share
|
|
Aug 26
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Indirect |
6,240
+9.41%
|
$68,640
$11.62 P/Share
|
|
Aug 26
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
14,560
+4.27%
|
$160,160
$11.79 P/Share
|
|
Aug 25
2021
|
Richard Aguilar Chief Clinical Officer |
BUY
Open market or private purchase
|
Direct |
51,393
+50.0%
|
$565,323
$11.93 P/Share
|
|
Aug 25
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Indirect |
53,857
+50.0%
|
$592,427
$11.94 P/Share
|
|
Aug 25
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
54,727
+14.94%
|
$601,997
$11.93 P/Share
|
|
Aug 20
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
10,000
+3.75%
|
$100,000
$10.2 P/Share
|
|
Aug 19
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
25,000
+9.19%
|
$250,000
$10.38 P/Share
|
|
Aug 18
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
11,900
+5.09%
|
$107,100
$9.82 P/Share
|
|
Aug 18
2021
|
David J Armstrong |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
$150,000
$10.02 P/Share
|
|
Aug 17
2021
|
Marlow Hernandez |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+30.0%
|
$810,000
$9.55 P/Share
|
|
Aug 16
2021
|
Marlow Hernandez |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+50.0%
|
$1,200,000
$10.16 P/Share
|
|
Jul 21
2021
|
Barry S Sternlicht Director |
SELL
Other acquisition or disposition
|
Indirect |
4,383,669
-11.18%
|
-
|
|
Jul 21
2021
|
Jaws Sponsor LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
17,175,000
-100.0%
|
-
|